Literature DB >> 1544835

Sensitivity to chemical oxidants and radiation in CHO cell lines deficient in oxidative pentose cycle activity.

S W Tuttle1, M E Varnes, J B Mitchell, J E Biaglow.   

Abstract

In this paper we examine the susceptibility of a series of G6PD- CHO cell lines to a variety of chemical oxidants. Addition of these drugs to K1D, the parental cell line, results in as much as a 20-fold increase in pentose cycle (PC) activity over control values. In two of our mutant lines, E16 and E48, little or no stimulation of PC activity is seen. These lines are shown to be much more susceptible to the toxic effects of the chemical oxidants t-butyl hydroperoxide and diamide. PC activity is also stimulated by ionizing radiation in K1D cells. One of the G6PD- cell lines has an increased aerobic radiation response compared to the parental line. However, since this is not the case with the other G6PD- cell lines, it is unclear whether this represents a difference in the absolute value of PC activity or some additional variable that may be influencing the results.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544835     DOI: 10.1016/0360-3016(92)90500-h

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  Late ROS accumulation and radiosensitivity in SOD1-overexpressing human glioma cells.

Authors:  Zhen Gao; Ehab H Sarsour; Amanda L Kalen; Ling Li; Maneesh G Kumar; Prabhat C Goswami
Journal:  Free Radic Biol Med       Date:  2008-08-14       Impact factor: 7.376

2.  Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis.

Authors:  Daniel R Wahl; Joseph Dresser; Kari Wilder-Romans; Joshua D Parsels; Shuang G Zhao; Mary Davis; Lili Zhao; Maureen Kachman; Stefanie Wernisch; Charles F Burant; Meredith A Morgan; Felix Y Feng; Corey Speers; Costas A Lyssiotis; Theodore S Lawrence
Journal:  Cancer Res       Date:  2016-12-06       Impact factor: 12.701

3.  Intracellular reduction of selenite into glutathione peroxidase. Evidence for involvement of NADPH and not glutathione as the reductant.

Authors:  S Bhamre; R L Nuzzo; J C Whitin; R A Olshen; H J Cohen
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

4.  Decreased ability of cells overexpressing MYC proteins to reduce peroxide and hydroperoxides.

Authors:  S Tuttle; R Muschel; E Bernhard; W G McKenna; J Biaglow
Journal:  Br J Cancer Suppl       Date:  1996-07

5.  2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells.

Authors:  Andrean L Simons; Iman M Ahmad; David M Mattson; Kenneth J Dornfeld; Douglas R Spitz
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

6.  Radiosensitive gene therapy through imRNA expression for silencing manganese superoxide dismutase.

Authors:  Yaming Qu; Suping Zhao; Jidong Hong; Sane Tang
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-11       Impact factor: 4.553

7.  Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress.

Authors:  Tanja Hadzic; Nükhet Aykin-Burns; Yueming Zhu; Mitchell C Coleman; Katie Leick; Geraldine M Jacobson; Douglas R Spitz
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

8.  2-Deoxyglucose combined with wild-type p53 overexpression enhances cytotoxicity in human prostate cancer cells via oxidative stress.

Authors:  Iman M Ahmad; Maher Y Abdalla; Nukhet Aykin-Burns; Andrean L Simons; Larry W Oberley; Frederick E Domann; Douglas R Spitz
Journal:  Free Radic Biol Med       Date:  2007-11-28       Impact factor: 7.376

9.  Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming.

Authors:  F Zhao; A Mancuso; T V Bui; X Tong; J J Gruber; C R Swider; P V Sanchez; J J Lum; N Sayed; J V Melo; A E Perl; M Carroll; S W Tuttle; C B Thompson
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

10.  Posttreatment FDG-PET uptake in the supraglottic and glottic larynx correlates with decreased quality of life after chemoradiotherapy.

Authors:  Ken Dornfeld; Shane Hopkins; Joel Simmons; Douglas R Spitz; Yusuf Menda; Michael Graham; Russell Smith; Gerry Funk; Lucy Karnell; Michael Karnell; Maude Dornfeld; Min Yao; John Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.